Oramed Pharmaceuticals Inc. Revenue 2016–2025
Oramed Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Oramed Pharmaceuticals Inc. revenue for the quarter ending March 31, 2025 was 2.0 M, a 200.30% increase year-over-year.
- Oramed Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2025 was 4.0 M, a 37.83% increase year-over-year.
- Oramed Pharmaceuticals Inc. annual revenue for 2025 was 2.0 M, a 49.25% increase from 2023.
- Oramed Pharmaceuticals Inc. annual revenue for 2023 was 1.3 M, a 50.43% decrease from 2022.
- Oramed Pharmaceuticals Inc. annual revenue for 2022 was 2.7 M, a 0.00% increase from 2021.
- Oramed Pharmaceuticals Inc. annual revenue for 2021 was 2.7 M.
Oramed Pharmaceuticals Inc. (ORMP) — Frequently Asked Questions
Oramed Pharmaceuticals Inc. (ORMP) is a publicly traded US company. It has a market capitalization of $162M. In fiscal 2025 it reported revenue of $2M and net income of $64M. Explore ORMP's stock price, financial statements, earnings history, margins and key ratios below.
What is Oramed Pharmaceuticals Inc.'s market cap?
Oramed Pharmaceuticals Inc. (ORMP) has a market capitalization of $162M.
What is the ORMP stock price?
ORMP trades at $3.83 (+3.38% on the day).
How much revenue does Oramed Pharmaceuticals Inc. make?
Oramed Pharmaceuticals Inc. reported revenue of $2M in fiscal 2025.
Is ORMP profitable?
In fiscal 2025, Oramed Pharmaceuticals Inc. reported net income of $64M.